<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK487394" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK487394/" /><meta name="ncbi_pagename" content="Schwannomatosis - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Schwannomatosis - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Schwannomatosis" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/03/08" /><meta name="citation_author" content="Radhika Dhamija" /><meta name="citation_author" content="Scott Plotkin" /><meta name="citation_author" content="Ashok Asthagiri" /><meta name="citation_author" content="Ludwine Messiaen" /><meta name="citation_author" content="Dusica Babovic-Vuksanovic" /><meta name="citation_pmid" content="29517885" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK487394/" /><meta name="citation_keywords" content="Congenital Cutaneous Neurilemmomatosis" /><meta name="citation_keywords" content="Leucine-zipper-like transcriptional regulator 1" /><meta name="citation_keywords" content="SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1" /><meta name="citation_keywords" content="LZTR1" /><meta name="citation_keywords" content="SMARCB1" /><meta name="citation_keywords" content="Schwannomatosis" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Schwannomatosis" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Radhika Dhamija" /><meta name="DC.Contributor" content="Scott Plotkin" /><meta name="DC.Contributor" content="Ashok Asthagiri" /><meta name="DC.Contributor" content="Ludwine Messiaen" /><meta name="DC.Contributor" content="Dusica Babovic-Vuksanovic" /><meta name="DC.Date" content="2018/03/08" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK487394/" /><meta name="description" content="Schwannomatosis is characterized by a predisposition to develop multiple schwannomas and, less frequently, meningiomas. Individuals with schwannomatosis most commonly present between the second and fourth decade of life. The most common presenting feature is localized or diffuse pain or asymptomatic mass. Schwannomas most often affect peripheral nerves and spinal nerves. Meningiomas occur in about 5% of individuals with schwannomatosis and have only been reported in individuals with SMARCB1-related schwannomatosis. Malignancy remains a theoretic risk especially in individuals with a SMARCB1 pathogenic variant." /><meta name="og:title" content="Schwannomatosis" /><meta name="og:type" content="book" /><meta name="og:description" content="Schwannomatosis is characterized by a predisposition to develop multiple schwannomas and, less frequently, meningiomas. Individuals with schwannomatosis most commonly present between the second and fourth decade of life. The most common presenting feature is localized or diffuse pain or asymptomatic mass. Schwannomas most often affect peripheral nerves and spinal nerves. Meningiomas occur in about 5% of individuals with schwannomatosis and have only been reported in individuals with SMARCB1-related schwannomatosis. Malignancy remains a theoretic risk especially in individuals with a SMARCB1 pathogenic variant." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK487394/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/schwann/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK487394/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D90B1E04184A1000000000015000C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK487394_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK487394_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/schmid-mcd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/spr-def/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK487394_"><span class="title" itemprop="name">Schwannomatosis</span></h1><p class="contrib-group"><span itemprop="author">Radhika Dhamija</span>, MD, <span itemprop="author">Scott Plotkin</span>, MD, PhD, <span itemprop="author">Ashok Asthagiri</span>, MD, <span itemprop="author">Ludwine Messiaen</span>, PhD, and <span itemprop="author">Dusica Babovic-Vuksanovic</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK487394_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK487394_ai__"><div class="contrib half_rhythm"><span itemprop="author">Radhika Dhamija</span>, MD<div class="affiliation small">Department of Clinical Genomics and Neurology<br />Mayo Clinic<br />Phoenix, Arizona<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.oyam@akihdar.ajimahd" class="oemail">ude.oyam@akihdar.ajimahd</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Scott Plotkin</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />Harvard Medical School and Massachusetts General Hospital<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.hgm@niktolps" class="oemail">ude.dravrah.hgm@niktolps</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ashok Asthagiri</span>, MD<div class="affiliation small">Department of Neurosurgery<br />University of Virginia<br />Charlottesville, Virginia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ainigriv.ccm.liamcsh@x5ara" class="oemail">ude.ainigriv.ccm.liamcsh@x5ara</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ludwine Messiaen</span>, PhD<div class="affiliation small">Department of Genetics<br />University of Alabama<br />Birmingham, Alabama<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.bau@neaisseml" class="oemail">ude.bau@neaisseml</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Dusica Babovic-Vuksanovic</span>, MD<div class="affiliation small">Department of Clinical Genomics<br />Mayo Clinic<br />Rochester, Minnesota<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.oyam@civobabd" class="oemail">ude.oyam@civobabd</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">March 8, 2018</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="schwann.Summary" itemprop="description"><h2 id="_schwann_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Schwannomatosis is characterized by a predisposition to develop multiple schwannomas and, less frequently, meningiomas. Individuals with schwannomatosis most commonly present between the second and fourth decade of life. The most common presenting feature is localized or diffuse pain or asymptomatic mass. Schwannomas most often affect peripheral nerves and spinal nerves. Meningiomas occur in about 5% of individuals with schwannomatosis and have only been reported in individuals with <i>SMARCB1</i>-related schwannomatosis. Malignancy remains a theoretic risk especially in individuals with a <i>SMARCB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of schwannomatosis is established based on clinical criteria or combined molecular and clinical criteria. Combined criteria include identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SMARCB1</i> or <i>LZTR1</i> in an individual with a pathologically confirmed schwannoma or meningioma.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Comprehensive, multimodal approach to pain management, guided by a pain management specialist or neurologist; referral to mental health professionals as needed for anxiety and/or depression; surgery for schwannomas associated with uncontrolled localized pain or a neurologic deficit; meningioma treatment as for <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> meningioma.</p><p><i>Surveillance</i>: At least annual imaging of intracranial schwannomas and spinal schwannomas as they can potentially cause spinal cord compression.</p><p><i>Evaluation of relatives at risk:</i> It is appropriate to evaluate apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from surveillance and clinical management.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Schwannomatosis is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Fewer than 20% of individuals have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. The proportion of cases caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is approximately 30% for <i>LZTR1-</i>related schwannomatosis and 10% for <i>SMARCB1-</i>related schwannomatosis. Penetrance is less than 100%. The risk to each offspring of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is 50%. Once the <i>LZTR1</i> or <i>SMARCB1</i> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="schwann.Diagnosis"><h2 id="_schwann_Diagnosis_">Diagnosis</h2><div id="schwann.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Schwannomatosis <b>should be suspected</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the following:</p><ul><li class="half_rhythm"><div>Two or more non-intradermal tumors suggestive of schwannomas</div></li><li class="half_rhythm"><div>No history of vestibular schwannomas</div></li><li class="half_rhythm"><div>A family history of schwannomatosis</div></li></ul></div><div id="schwann.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>A diagnosis of schwannomatosis <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the following <a href="#schwann.Clinical_Criteria">clinical criteria</a> or <a href="#schwann.Combined_Molecular_and_Clinical">combined molecular and clinical criteria</a> recently proposed by <a class="bk_pop" href="#schwann.REF.kehrersawatzki.2017.129">Kehrer-Sawatzki et al [2017]</a>.</p><div id="schwann.Clinical_Criteria"><h4>Clinical Criteria</h4><p>Either of the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">Two or more non-intradermal schwannomas (at least one biopsy-confirmed) AND no evidence of bilateral vestibular schwannomas by high-quality MRI examination and detailed study of internal auditory canal (with and without gadolinium and with slices &#x02264;3 mm)</div><div class="half_rhythm">Note: Presence of a unilateral vestibular schwannoma or meningioma(s) does not exclude the diagnosis.</div></li><li class="half_rhythm"><div class="half_rhythm">One pathologically confirmed schwannoma, unilateral vestibular schwannoma, or intracranial meningioma AND an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a> with confirmed schwannomatosis</div></li></ul></div><div id="schwann.Combined_Molecular_and_Clinical"><h4>Combined Molecular and Clinical Criteria</h4><p>Either of the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">A <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>SMARCB1</i> or <i>LZTR1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> AND one pathologically confirmed schwannoma or meningioma</div></li><li class="half_rhythm"><div class="half_rhythm">Two or more tumors (schwannoma, meningioma) each with 22q <a class="def" href="/books/n/gene/glossary/def-item/loss-of-heterozygosity/">loss of heterozygosity</a> and each with a different <a class="def" href="/books/n/gene/glossary/def-item/somatic-pathogenic-variant/">somatic pathogenic variant</a> of <i>NF2</i>* AND two or more pathologically confirmed schwannomas or meningiomas AND none of the <a href="#schwann.Exclusion_Criteria">exclusion criteria</a></div><div class="half_rhythm">* The 22q deletions should have different breakpoints indicative of independent events.</div></li></ul></div><div id="schwann.Exclusion_Criteria"><h4>Exclusion Criteria</h4><p>Any of the following:</p><ul><li class="half_rhythm"><div>A clinical diagnosis of <a href="/books/n/gene/nf2/">neurofibromatosis 2</a></div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>NF2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></div></li><li class="half_rhythm"><div>Schwannomas only within a radiation treatment field</div></li></ul><p>Note: In some instances, it may be difficult to distinguish between schwannomatosis and mosaic <a href="/books/n/gene/nf2/">neurofibromatosis 2</a> (see <a href="#schwann.Differential_Diagnosis">Differential Diagnosis</a>).</p><p>See <a href="#schwann.Molecular_Pathogenesis">Molecular Pathogenesis</a> for a hypothesis regarding the development of <i>SMARCB1</i>- or <i>LZTR1</i>-related schwannomatosis resulting from <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> inactivation of <i>SMARCB1</i> or <i>LZTR1</i> and biallelic inactivation of <i>NF2</i>.</p><p>Molecular genetic testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>LZTR1</i> and <i>SMARCB1</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>LZTR1, SMARCB1</i>, and other genes of interest (see <a href="#schwann.Differential_Diagnosis">Differential Diagnosis</a>) can be considered. Note: (1) The genes included and the <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of multigene panels vary by laboratory and are likely to change over time. In some laboratories, panel options may include custom laboratory-designed panels and/or custom <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. Thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of pathogenic variants or variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> in genes that do not explain the underlying phenotype. (3) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="schwann.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Schwannomatosis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK487394/table/schwann.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__schwann.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Schwannomatosis Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by This Method</th></tr><tr><th headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_2" id="hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Familial</th><th headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_2" id="hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sporadic</th><th headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<br /><a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LZTR1</i></td><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_2 hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~38%&#x000a0;<sup>6</sup></td><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_2 hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~30%&#x000a0;<sup>6</sup></td><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_3 hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_3 hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMARCB1</i></td><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_2 hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~48%&#x000a0;<sup>6</sup></td><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_2 hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~10%&#x000a0;<sup>6</sup></td><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_3 hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_3 hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 individual&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>9</sup></td><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_2 hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~14%</td><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_2 hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~60%</td><td headers="hd_h_schwann.T.molecular_genetic_testing_used_1_1_1_3 hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_3 hd_h_schwann.T.molecular_genetic_testing_used_1_1_2_4" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="schwann.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="schwann.TF.1.2"><p class="no_margin">See <a href="/books/NBK487394/#schwann.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="schwann.TF.1.3"><p class="no_margin">See <a href="#schwann.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="schwann.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="schwann.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="schwann.TF.1.6"><p class="no_margin">Estimates are derived from studies of individuals diagnosed with schwannomatosis according to clinical diagnostic criteria without preselection for those patients who have been shown to harbor different somatic <i>NF2</i> pathogenic variants in at least two different schwannomas [<a class="bk_pop" href="#schwann.REF.boyd.2008.358">Boyd et al 2008</a>, <a class="bk_pop" href="#schwann.REF.hadfield.2008.332">Hadfield et al 2008</a>, <a class="bk_pop" href="#schwann.REF.sestini.2008.227">Sestini et al 2008</a>, <a class="bk_pop" href="#schwann.REF.rousseau.2011.9">Rousseau et al 2011</a>, <a class="bk_pop" href="#schwann.REF.smith.2012.141">Smith et al 2012</a>, <a class="bk_pop" href="#schwann.REF.hutter.2014.449">Hutter et al 2014</a>, <a class="bk_pop" href="#schwann.REF.smith.2014.373">Smith et al 2014</a>, <a class="bk_pop" href="#schwann.REF.smith.2015.141">Smith et al 2015</a>].</p></div></dd><dt>7. </dt><dd><div id="schwann.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>8. </dt><dd><div id="schwann.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#schwann.REF.hulsebos.2016.350">Hulsebos et al [2016]</a> reported one individual with a ~7.7-kb <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>SMARCB1</i> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> that included <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 7.</p></div></dd><dt>9. </dt><dd><div id="schwann.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#schwann.REF.kehrersawatzki.2017.129">Kehrer-Sawatzki et al [2017]</a></p></div></dd></dl></div></div></div></div></div></div><div id="schwann.Clinical_Characteristics"><h2 id="_schwann_Clinical_Characteristics_">Clinical Characteristics</h2><div id="schwann.Clinical_Description"><h3>Clinical Description</h3><p>Schwannomatosis is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> tumor suppressor syndrome with reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, characterized by a predisposition to develop multiple schwannomas (histologically benign nerve sheath tumors) and much less frequently meningiomas [<a class="bk_pop" href="#schwann.REF.merker.2012.1317">Merker et al 2012</a>]. Individuals with schwannomatosis most commonly present between the second and fourth decade of life. Individuals with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> schwannomatosis usually present later than those with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> schwannomatosis [<a class="bk_pop" href="#schwann.REF.antinheimo.2000.71">Antinheimo et al 2000</a>, <a class="bk_pop" href="#schwann.REF.gonzalvo.2011.756">Gonzalvo et al 2011</a>, <a class="bk_pop" href="#schwann.REF.koontz.2013.w64653">Koontz et al 2013</a>]. The most common clinical symptom is either localized or diffuse pain [<a class="bk_pop" href="#schwann.REF.merker.2012.1317">Merker et al 2012</a>, <a class="bk_pop" href="#schwann.REF.li.2016.145">Li et al 2016</a>, <a class="bk_pop" href="#schwann.REF.ostrow.2017.407">Ostrow et al 2017</a>]. Another presenting symptom can be an asymptomatic mass. Focal weakness and/or muscle atrophy rarely occur as the only presenting sign of schwannomatosis [<a class="bk_pop" href="#schwann.REF.ostrow.2017.407">Ostrow et al 2017</a>].</p><p><b>Schwannomas</b> most often affect peripheral nerves (90%) and spinal nerves (75%) [<a class="bk_pop" href="#schwann.REF.merker.2012.1317">Merker et al 2012</a>]. Among the spinal nerves, the lumbar spine is most commonly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> [<a class="bk_pop" href="#schwann.REF.li.2016.145">Li et al 2016</a>]. Although cranial nerve involvement is rare, the most common cranial nerve affected is the trigeminal nerve [<a class="bk_pop" href="#schwann.REF.gonzalvo.2011.756">Gonzalvo et al 2011</a>]. Unilateral vestibular schwannomas can occur in individuals with schwannomatosis, but bilateral vestibular schwannoma is an exclusion criterion as these individuals fulfill diagnostic criteria for <a href="/books/n/gene/nf2/">neurofibromatosis 2</a> [<a class="bk_pop" href="#schwann.REF.smith.2017.87">Smith et al 2017</a>].</p><p>In a study of 51 individuals with schwannomatosis imaged by whole-body MRI examination, 36 (71%) of the 51 individuals had internal nerve sheath tumors &#x02013;81% of which were discrete; three (8%) individuals had plexiform neurofibromas, and the remaining individuals had both tumor types [<a class="bk_pop" href="#schwann.REF.plotkin.2012.e35711">Plotkin et al 2012</a>].</p><p><b>Meningiomas</b> occur in about 5% of individuals with schwannomatosis [<a class="bk_pop" href="#schwann.REF.merker.2012.1317">Merker et al 2012</a>] and have only been reported in individuals with <i>SMARCB1</i> pathogenic variants [<a class="bk_pop" href="#schwann.REF.bacci.2010.73">Bacci et al 2010</a>, <a class="bk_pop" href="#schwann.REF.christiaans.2011.93">Christiaans et al 2011</a>].</p><p><b>Malignancy.</b> Malignant transformation of schwannomas remains a theoretic risk as in other tumor suppressor syndromes [<a class="bk_pop" href="#schwann.REF.evans.2012.17">Evans et al 2012</a>]. Malignant schwannomas were identified in two individuals with clinically diagnosed <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> schwannomatosis [<a class="bk_pop" href="#schwann.REF.gonzalvo.2011.756">Gonzalvo et al 2011</a>]. In a large retrospective analysis of 87 individuals with schwannomatosis, three individuals were diagnosed with malignant peripheral nerve sheath tumors (MPNSTs) but subsequent reanalysis by an experienced neuropathologist led to reclassification of these MPNSTs to cellular schwannoma (2 tumors) and melanoma (1 tumor) [<a class="bk_pop" href="#schwann.REF.merker.2012.1317">Merker et al 2012</a>]. Thus, the exact risk of malignant transformation remains unclear. Rapid growth of a schwannoma and intractable pain should raise concern for the possibility of malignancy.</p><p><b>Pain</b> is a very common comorbid condition in individuals with schwannomatosis and may not always localize to the site of the schwannoma. Increased tumor volume was associated with higher levels of pain in an analysis of 51 individuals with schwannomatosis imaged with whole-body MRI examination [<a class="bk_pop" href="#schwann.REF.merker.2014.1431">Merker et al 2014</a>]. Pain often becomes chronic and is associated with anxiety and depression [<a class="bk_pop" href="#schwann.REF.gonzalvo.2011.756">Gonzalvo et al 2011</a>, <a class="bk_pop" href="#schwann.REF.merker.2012.1317">Merker et al 2012</a>]. Quality of life measurement scores are decreased in individuals with schwannomatosis [<a class="bk_pop" href="#schwann.REF.merker.2014.1431">Merker et al 2014</a>].</p><p><b>Segmental schwannomatosis.</b> In about one third of individuals with schwannomatosis, schwannomas are limited to one extremity, one side of the body, or a limited region of the spine (typically &#x0003c;5 contiguous segments) [<a class="bk_pop" href="#schwann.REF.koontz.2013.w64653">Koontz et al 2013</a>]. Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> has been proposed as a mechanism for segmental schwannomatosis, although this is not yet established. A recent study of five individuals with clinically diagnosed segmental schwannomatosis identified subtle fascicular lesions by magnetic resonance neurography in four of five individuals in clinically unaffected limbs; two of the five individuals had <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>LZTR1</i> pathogenic variants. The presence of subtle disease beyond the clinically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> region argues against a purely segmental disease and suggests the possibility of other genetic modifiers [<a class="bk_pop" href="#schwann.REF.farschtschi.2016.625">Farschtschi et al 2016</a>].</p><p>Note: Cutaneous manifestations including caf&#x000e9; au lait macules, skin-fold freckling, and cutaneous schwannomas typical of other forms of neurofibromatosis are not features of schwannomatosis.</p></div><div id="schwann.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p><b><i>SMARCB1.</i></b> Meningiomas have been reported in individuals with <i>SMARCB1-</i>related schwannomatosis [<a class="bk_pop" href="#schwann.REF.bacci.2010.73">Bacci et al 2010</a>, <a class="bk_pop" href="#schwann.REF.christiaans.2011.93">Christiaans et al 2011</a>, <a class="bk_pop" href="#schwann.REF.melean.2012.267">Melean et al 2012</a>, <a class="bk_pop" href="#schwann.REF.van_den_munckhof.2012.1">van den Munckhof et al 2012</a>].</p><p><b><i>LZTR1.</i></b> To date no individuals with <i>LZTR1-</i>related schwannomatosis have been reported to have meningiomas.</p></div><div id="schwann.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>In general, <i>SMARCB1</i> pathogenic variants that predispose to <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> schwannomatosis are more likely to be nontruncating (e.g., <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>) and are most commonly located at either the 5' or 3' end of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Individuals with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> schwannomatosis are more likely to have truncating (e.g., frameshift, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>) <i>SMARCB1</i> pathogenic variants [<a class="bk_pop" href="#schwann.REF.rousseau.2011.9">Rousseau et al 2011</a>].</p><p>Germline truncating <i>SMARCB1</i> variants (e.g., frameshift, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>), deletions of one or more exons, or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the entire <i>SMARCB1</i> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is found in 15%-60% of individuals with <a href="/books/n/gene/rtps/">rhabdoid tumors</a> [<a class="bk_pop" href="#schwann.REF.bourdeaut.2011.31">Bourdeaut et al 2011</a>, <a class="bk_pop" href="#schwann.REF.eaton.2011.7">Eaton et al 2011</a>]. Truncating <i>SMARCB1</i> variants and deletions of one or more exons are most commonly seen in the central part of the gene (see <a href="#schwann.Genetically_Related_Allelic_Diso">Genetically Related Disorders</a>) [<a class="bk_pop" href="#schwann.REF.smith.2014.373">Smith et al 2014</a>]. Rhabdoid and atypical teratoid tumors have rarely also been reported in some members of families with <i>SMARCB1</i>-related schwannomatosis [<a class="bk_pop" href="#schwann.REF.swensen.2009.68">Swensen et al 2009</a>, <a class="bk_pop" href="#schwann.REF.eaton.2011.7">Eaton et al 2011</a>].</p></div><div id="schwann.Penetrance"><h3>Penetrance</h3><p>The data on <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> are limited, though it is less than 100% for both <i>SMARCB1-</i> [<a class="bk_pop" href="#schwann.REF.swensen.2009.68">Swensen et al 2009</a>, <a class="bk_pop" href="#schwann.REF.plotkin.2013.405">Plotkin et al 2013</a>] and <i>LZTR1-</i>related schwannomatosis<i>.</i> Reduced penetrance is more frequently reported in individuals with <i>LZTR1-</i>related schwannomatosis [<a class="bk_pop" href="#schwann.REF.piotrowski.2014.182">Piotrowski et al 2014</a>, <a class="bk_pop" href="#schwann.REF.paganini.2015.963">Paganini et al 2015</a>, <a class="bk_pop" href="#schwann.REF.smith.2015.141">Smith et al 2015</a>, <a class="bk_pop" href="#schwann.REF.gripp.2017.540">Gripp et al 2017</a>].</p></div><div id="schwann.Nomenclature"><h3>Nomenclature</h3><p>Schwannomatosis has been referred to as the third form of neurofibromatosis.</p><p>Previous terminology for this condition has included multiple neurilemomas, multiple schwannomas, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neurilemomatosis.</p></div><div id="schwann.Prevalence"><h3>Prevalence</h3><p>Schwannomatosis is a rare disorder with an estimated prevalence of around 1/70,000. This is likely an underestimate given difficulty in identifying <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#schwann.REF.maccollin.2005.1838">MacCollin et al 2005</a>, <a class="bk_pop" href="#schwann.REF.koontz.2013.w64653">Koontz et al 2013</a>, <a class="bk_pop" href="#schwann.REF.plotkin.2013.405">Plotkin et al 2013</a>, <a class="bk_pop" href="#schwann.REF.kehrersawatzki.2017.129">Kehrer-Sawatzki et al 2017</a>, <a class="bk_pop" href="#schwann.REF.smith.2017.87">Smith et al 2017</a>].</p></div></div><div id="schwann.Genetically_Related_Allelic_Diso"><h2 id="_schwann_Genetically_Related_Allelic_Diso_">Genetically Related (Allelic) Disorders</h2><p><a class="figpopup" href="/books/NBK487394/table/schwann.T.allelic_disorders/?report=objectonly" target="object" rid-figpopup="figschwannTallelicdisorders" rid-ob="figobschwannTallelicdisorders">Table 2</a> includes other phenotypes caused by pathogenic variants in the genes associated with schwannomatosis.</p><div id="schwann.T.allelic_disorders" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Allelic Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK487394/table/schwann.T.allelic_disorders/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__schwann.T.allelic_disorders_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_schwann.T.allelic_disorders_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_schwann.T.allelic_disorders_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_schwann.T.allelic_disorders_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_schwann.T.allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LZTR1</i></td><td headers="hd_h_schwann.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Noonan syndrome type 10</td><td headers="hd_h_schwann.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/616564" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616564</a></td></tr><tr><td headers="hd_h_schwann.T.allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMARCB1</i></td><td headers="hd_h_schwann.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Coffin-Siris syndrome&#x000a0;<sup>2</sup><br />Rhabdoid tumor predisposition syndrome</td><td headers="hd_h_schwann.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/coffin-siris/">Coffin-Siris Syndrome</a><br /><a href="/books/n/gene/rtps/">Rhabdoid Tumor Predispostition Syndrome</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="schwann.TF.2.1"><p class="no_margin">See hyperlinked <i>GeneReview</i>, OMIM <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> entry, or cited reference for more information.</p></div></dd><dt>2. </dt><dd><div id="schwann.TF.2.2"><p class="no_margin">An individual with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> <i>SMARCB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> with both Coffin-Siris <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and schwannomatosis was reported by <a class="bk_pop" href="#schwann.REF.gossai.2015.3186">Gossai et al [2015]</a>.</p></div></dd></dl></div></div></div><p>Sporadic meningiomas and <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> glioblastomas occurring as single tumors in the absence of any other findings of schwannomatosis may harbor somatic variants in <i>SMARCB1</i> or <i>LZTR1</i> (respectively) that are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>. In these circumstances predisposition to these tumors is not heritable (see <a href="#schwann.Cancer_and_Benign_Tumors">Cancer and Benign Tumors</a>).</p></div><div id="schwann.Differential_Diagnosis"><h2 id="_schwann_Differential_Diagnosis_">Differential Diagnosis</h2><div id="schwann.T.disorders_to_consider_in_the_d" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Schwannomatosis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK487394/table/schwann.T.disorders_to_consider_in_the_d/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__schwann.T.disorders_to_consider_in_the_d_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of This Disorder</th></tr><tr><th headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_4" id="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/schwannomatosis</th><th headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_4" id="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from schwannomatosis</th></tr></thead><tbody><tr><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/nf1/">Neurofibromatosis 1</a></td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NF1</i></td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Peripheral nerve sheath tumors (neurofibromas)</div></li><li class="half_rhythm"><div>MPNST</div></li></ul>
</td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cutaneous stigmata w/<i>caf&#x000e9; au lait</i> macules &#x00026; freckling</td></tr><tr><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/nf2/">Neurofibromatosis 2</a></td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NF2</i></td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Peripheral nerve sheath tumors (schwannomas)</div></li><li class="half_rhythm"><div>Unilateral vestibular schwannoma</div></li><li class="half_rhythm"><div>Meningioma</div></li></ul>
</td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Bilateral vestibular schwannomas</div></li><li class="half_rhythm"><div>Ependymomas</div></li><li class="half_rhythm"><div>Cataracts</div></li><li class="half_rhythm"><div>Retinal hamartomas</div></li><li class="half_rhythm"><div>Epiretinal membrane</div></li><li class="half_rhythm"><div>Intradermal schwannomas</div></li><li class="half_rhythm"><div>Cutaneous schwannomas</div></li></ul>
</td></tr><tr><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/carney/">Carney complex</a></td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRKAR1A</i></td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Schwannomas or psammomatous melanotic schwannomas</td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Endocrine features</div></li><li class="half_rhythm"><div>Cardiac &#x00026; skin myxomas</div></li><li class="half_rhythm"><div>Pigmented skin lesions</div></li></ul>
</td></tr><tr><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Meningioma, <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a>, susceptibility to (OMIM <a href="http://omim.org/entry/607174" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">607174</a>)</td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMARCE1</i><br /><i>SUFU</i>&#x000a0;<sup>1</sup></td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Meningioma</td><td headers="hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_schwann.T.disorders_to_consider_in_the_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; MPNST = malignant peripheral nerve sheath tumor</p></div></dd><dt>1. </dt><dd><div id="schwann.TF.3.1"><p class="no_margin"><a class="bk_pop" href="#schwann.REF.aavikko.2012.520">Aavikko et al [2012]</a></p></div></dd></dl></div></div></div><p><a href="/books/n/gene/nf2/"><b>Neurofibromatosis 2</b></a><b>.</b> It may be difficult to distinguish between mosaic neurofibromatosis 2 (NF2) and schwannomatosis in an individual presenting with multiple schwannomas in the absence of vestibular schwannomas or a family history of NF2 or schwannomatosis. Molecular genetic testing of <i>LZTR1, SMARCB1,</i> and <i>NF2</i> using DNA derived from blood and at least two tumor samples from anatomically unrelated locations is recommended to distinguish between these conditions (see <a href="#schwann.Establishing_the_Diagnosis">Establishing the Diagnosis</a>).</p></div><div id="schwann.Management"><h2 id="_schwann_Management_">Management</h2><div id="schwann.Evaluations_Following_Initial_Di"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with schwannomatosis, the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Detailed family and personal clinical history</div></li><li class="half_rhythm"><div>Brain and spine MRI examination to establish the extent of disease</div></li><li class="half_rhythm"><div>MRI examination of peripheral nervous system based on symptoms</div></li><li class="half_rhythm"><div>Consultation with a neurologist and a neurosurgeon as symptoms indicate</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="schwann.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Pain management</b>. Various pain medications (e.g., calcium channel alpha 2 delta ligands such as gabapentin, tricyclic antidepressants such as amitriptyline, serotonin-norepinephrine reuptake inhibitors such as venlafaxine) may be helpful individually or as adjuncts. No class of pain medication appears to be better than another [Author, personal communication]. A comprehensive, multimodal approach to pain management guided by a pain management specialist or neurologist provides an opportunity for long-term management of symptoms without surgical intervention.</p><p><b>Emotional health.</b> Pain management may improve anxiety and depression. Referral to mental health professionals may also be warranted.</p><p><b>Surgical management of peripheral nerve tumors.</b> Surgery is indicated for symptomatic schwannomas (e.g., uncontrolled localized pain related to a schwannoma, schwannoma resulting in a neurologic deficit). The principles for surgical resection of peripheral nerve tumors are similar to those utilized for resection of <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> nerve sheath tumors:</p><ul><li class="half_rhythm"><div>The potential benefits of surgery must be weighed carefully against the potential risks.</div></li><li class="half_rhythm"><div>Given the technical challenges involved in surgery, referral to an expert center with a peripheral nerve surgeon is recommended.</div></li><li class="half_rhythm"><div>It is important that surgery be performed in conjunction with ongoing pharmacologic pain management, as pain relief following tumor resection is not ensured.</div></li></ul><p><b>Management of spinal and cranial nerve tumors.</b> Performing surgery for each newly identified tumor is impractical and inadvisable. Therefore, delineation of "presymptomatic" tumors at initial evaluation (and each subsequent evaluation) is requisite to establishing a paradigm of expectant management for longitudinal observation. Affected individuals should be educated on the most common, early symptoms that suggest that an existing tumor is becoming problematic. Early identification and intervention for problematic tumors improves outcomes for many central nervous system tumors. Intraspinal schwannomas &#x0003e;5 mm in size warrant longitudinal imaging and clinical surveillance. Growing intraspinal schwannomas may cause significant impact to adjacent neural structures, and surgical removal at the time of early onset of symptoms remains the mainstay of treatment. This approach balances the need to maximize functional outcome and to avoid unnecessary prophylactic surgical intervention.</p><p>When considering surgical intervention for a cerebellopontine angle cranial nerve schwannoma it is important to consider historical cues, physical exam findings, and imaging observations that may help delineate a facial nerve etiology. Because hearing preservation and facial nerve preservation are significant considerations when making a decision to intervene on schwannomas of the internal auditory canal, these become critical in determining the timing of intervention. In general hearing preservation rates are dramatically reduced when vestibular schwannomas exceed 1 cm in size, and facial nerve function significantly declines when schwannomas exceed 2.5-3 cm. It remains unclear how best to translate the success seen with radiosurgery for <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> vestibular schwannoma management to those with schwannomatosis [<a class="bk_pop" href="#schwann.REF.kondziolka.1998.1426">Kondziolka et al 1998</a>].</p><p><b>Management of meningiomas.</b> There is a paucity of outcome data from surgical, radiosurgical, and radiation therapy for meningiomas in individuals with schwannomatosis. Therefore, management recommendations in individuals with schwannomatosis and meningioma are the same as for those with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> meningioma.</p><p><b>Radiation therapy.</b> There is a theoretic risk that radiation exposure can increase the risk for malignant transformation; however, this has not yet been demonstrated in individuals with schwannomatosis [<a class="bk_pop" href="#schwann.REF.evans.2006.289">Evans et al 2006</a>]. The exact role of this modality needs to be established.</p></div><div id="schwann.Surveillance"><h3>Surveillance</h3><p>Based on the 2016 American Association for Cancer Research Childhood Cancer Predisposition Workshop, surveillance guidelines have been proposed [<a class="bk_pop" href="#schwann.REF.evans.2017.e54">Evans et al 2017</a>].</p><p><b><i>SMARCB1-</i>related schwannomatosis</b></p><ul><li class="half_rhythm"><div>Baseline MRI examination of the brain and spine at diagnosis, then every two to three years beginning at age ten years</div></li><li class="half_rhythm"><div>Consideration of whole-body MRI examination and increasing surveillance frequency if symptomatic</div></li></ul><p><b><i>LZTR1-</i>related schwannomatosis</b> [<a class="bk_pop" href="#schwann.REF.plotkin.2012.e35711">Plotkin et al 2012</a>, <a class="bk_pop" href="#schwann.REF.merker.2014.1431">Merker et al 2014</a>, <a class="bk_pop" href="#schwann.REF.evans.2017.e54">Evans et al 2017</a>]</p><ul><li class="half_rhythm"><div>Baseline MRI examination of the brain and spine at diagnosis, then every two to three beginning at age 15 to 19 years</div></li><li class="half_rhythm"><div>Consideration of whole-body MRI examination and increasing surveillance frequency if symptomatic</div></li></ul><p>High cost and poor insurance reimbursement limit the wider use of whole-body MRI.</p></div><div id="schwann.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>There is a theoretic risk that radiation exposure can increase the risk for malignant transformation; however, this has not yet been demonstrated in individuals with schwannomatosis [<a class="bk_pop" href="#schwann.REF.evans.2006.289">Evans et al 2006</a>].</p></div><div id="schwann.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from surveillance and clinical management. Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing (after appropriate <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>) if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known;</div></li><li class="half_rhythm"><div>A through neurologic examination and history if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known.</div></li></ul><p>See <a href="#schwann.Related_Genetic_Counseling_Issue">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="schwann.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="schwann.Genetic_Counseling"><h2 id="_schwann_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="schwann.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Schwannomatosis is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner with incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p></div><div id="schwann.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Fewer than 20% of individuals diagnosed with schwannomatosis have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. There is clinical variability within families and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> [<a class="bk_pop" href="#schwann.REF.antinheimo.2000.71">Antinheimo et al 2000</a>, <a class="bk_pop" href="#schwann.REF.kehrersawatzki.2017.129">Kehrer-Sawatzki et al 2017</a>].</div></li><li class="half_rhythm"><div>Some individuals diagnosed with schwannomatosis have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>LZTR1</i> or <i>SMARCB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#schwann.REF.kehrersawatzki.2017.129">Kehrer-Sawatzki et al 2017</a>]. The proportion of <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases caused by a <i>de novo</i> pathogenic variant is approximately 30% for <i>LZTR1-</i>related schwannomatosis and 10% for <i>SMARCB1-</i>related schwannomatosis [<a class="bk_pop" href="#schwann.REF.kehrersawatzki.2017.129">Kehrer-Sawatzki et al 2017</a>].</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Germline mosaicism for a <i>SMARCB1</i> pathogenic variant has been reported in one family, and thus is far less frequent than in <a href="/books/n/gene/nf2/">neurofibromatosis 2</a> [<a class="bk_pop" href="#schwann.REF.hulsebos.2010.86">Hulsebos et al 2010</a>].</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with schwannomatosis may appear to be negative because of failure to recognize the disorder in family members, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is known to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <i>LZTR1</i> or <i>SMARCB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs is 50%. However, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is reduced and there is phenotypic variability within families.</div></li><li class="half_rhythm"><div>If the <i>LZTR1</i> or <i>SMARCB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#schwann.REF.hulsebos.2010.86">Hulsebos et al 2010</a>].</div></li><li class="half_rhythm"><div>The absence of clinical symptoms in parents whose genetic status is unknown cannot be used to predict risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent or the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with schwannomatosis has a 50% chance of inheriting the <i>LZTR1</i> or <i>SMARCB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. However, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is reduced and there is phenotypic variability within families.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>LZTR1</i> or <i>SMARCB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="schwann.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#schwann.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Predictive testing</b> for at-risk asymptomatic adult family members requires prior identification of the <i>LZTR1</i> or <i>SMARCB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption should also be considered.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="schwann.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>LZTR1</i> or <i>SMARCB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="schwann.Resources"><h2 id="_schwann_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Children's Tumor Foundation: Ending NF Through Research</b></div><div>120 Wall Street, 16th Floor</div><div>New York 10005-3904</div><div><b>Phone:</b> 800-323-7938</div><div><b>Email:</b> info@ctf.org</div><div><a href="http://www.ctf.org/understanding-nf/schwannomatosis" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Schwannomatosis</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/schwannomatosis" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Schwannomatosis</a></div></li><li class="half_rhythm"><div><b>Neurofibromatosis Network</b></div><div>213 South Wheaton Avenue</div><div>Wheaton IL 60187</div><div><b>Phone:</b> 800-942-6825</div><div><b>Fax:</b> 630-510-8508</div><div><b>Email:</b> admin@nfnetwork.org</div><div><a href="https://nfnetwork.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nfnetwork.org</a></div></li><li class="half_rhythm"><div><b> International Schwannomatosis Database (Registry)</b></div><div><i>Accelerating research by connecting families and scientists accelerating research by connecting families and scientists</i></div><div><a href="http://sid2011.squarespace.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Schwannomatosis Database Project</a></div></li></ul></div><div id="schwann.Molecular_Genetics"><h2 id="_schwann_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="schwann.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Schwannomatosis: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK487394/table/schwann.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__schwann.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_schwann.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_schwann.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_schwann.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_schwann.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_schwann.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_schwann.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_schwann.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8216" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>LZTR1</i></a></td><td headers="hd_b_schwann.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8216" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q11<wbr style="display:inline-block"></wbr>​.21</a></td><td headers="hd_b_schwann.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8N653" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Leucine-zipper-like transcriptional regulator 1</a></td><td headers="hd_b_schwann.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/LZTR1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LZTR1 @ LOVD</a></td><td headers="hd_b_schwann.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=LZTR1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LZTR1</a></td><td headers="hd_b_schwann.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=LZTR1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LZTR1</a></td></tr><tr><td headers="hd_b_schwann.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6598" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SMARCB1</i></a></td><td headers="hd_b_schwann.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6598" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q11<wbr style="display:inline-block"></wbr>​.23</a></td><td headers="hd_b_schwann.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q12824" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1</a></td><td headers="hd_b_schwann.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SMARCB1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMARCB1 database</a><br /><a href="https://www.uke.de/dateien/kliniken/paediatrische-haematologie-und-onkologie/dokumente/smarcb1/smarcb1_data_uke_2009-11-26.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UKE Hamburg SMARCB1 database</a></td><td headers="hd_b_schwann.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SMARCB1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMARCB1</a></td><td headers="hd_b_schwann.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SMARCB1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMARCB1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="schwann.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="schwann.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Schwannomatosis (<a href="/omim/162091,600574,601607,615670" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK487394/table/schwann.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__schwann.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/162091" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">162091</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SCHWANNOMATOSIS 1; SWNTS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600574" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600574</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEUCINE ZIPPER-LIKE TRANSCRIPTIONAL REGULATOR 1; LZTR1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601607" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601607</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY B, MEMBER 1; SMARCB1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615670" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615670</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SCHWANNOMATOSIS 2; SWNTS2</td></tr></tbody></table></div></div><div id="schwann.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The classic Knudson two-hit model of tumorigenesis does not suffice for tumor initiation or growth in <i>LZTR1-</i> or <i>SMARCB1</i>-related schwannomatosis. <i>LZTR1-</i> or <i>SMARCB1</i>-related schwannomatosis is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> inactivation of at least two tumor suppressor genes.</p><p>A hypothesis has been proposed for both <i>LZTR1-</i> and <i>SMARCB1-</i>related <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> schwannomatosis. The first hit is a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a> <i>SMARCB1</i> or <i>LZTR1</i> mutation event. The second event involves <a class="def" href="/books/n/gene/glossary/def-item/loss-of-heterozygosity/">loss of heterozygosity</a> through contiguous <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on 22q including the <a class="def" href="/books/n/gene/glossary/def-item/wild-type/">wild-type</a> <i>LZTR1</i>, <i>SMARCB1</i>, and <i>NF2</i> alleles. Thirdly, somatic inactivating mutation of the remaining <i>NF2</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, <i>in cis</i> with the <i>SMARCB1</i> or <i>LZTRI</i> first hit, occurs. Therefore, these events result in either <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> inactivation of <i>SMARCB1</i> (in <i>SMARCB1</i>-related schwannomatosis) or <i>LZTR1</i> (in <i>LZTR1</i>-related schwannomatosis) as well as the inactivation of both <i>NF2</i> alleles (in <i>SMARCB1</i>- as well as <i>LZTR1</i>-related schwannomatosis) [<a class="bk_pop" href="#schwann.REF.hadfield.2008.332">Hadfield et al 2008</a>, <a class="bk_pop" href="#schwann.REF.hadfield.2010.6216">Hadfield et al 2010</a>, <a class="bk_pop" href="#schwann.REF.piotrowski.2014.182">Piotrowski et al 2014</a>].</p><div id="schwann.LZTR1"><h4><i>LZTR1</i></h4><p><b>Gene structure.</b> The transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_006767.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006767.3</a> has 21 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK487394/#schwann.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b>
<i>LZTR1</i> pathogenic variants are distributed throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, and include truncating and out-of-frame <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> (~53%), <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> (~40%), and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants with <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> or unknown effect (~7%). Non-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>, and high percentage of missense variants renders the classification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> challenging. Few recurrent pathogenic variants have been seen.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein encoded by <i>LZTR1,</i> the leucin-zipper-like transcriptional regulator 1, has 840 amino acids and belongs to a functionally diverse superfamily of BTB/POZ (bric &#x000e0; brac, tramtrack, broad complex/pox virus and zinc-finger) proteins. LZTR1 contains an N-terminal Kelch <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> with six Kelch motifs followed by two BTB domains. It acts as a tumor suppressor; it is not known how it contributes to the pathogenesis of schwannomas.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Germline pathogenic variants are thought to be <a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a>, thereby resulting in <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of the protein.</p></div><div id="schwann.SMARCB1"><h4><i>SMARCB1</i></h4><p><b>Gene structure</b>. The transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003073.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003073.4</a> has nine exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, transcript, and protein information, see <a href="/books/NBK487394/#schwann.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Germline <i>SMARCB1</i> pathogenic variants found in individuals with schwannomatosis differ in position and type from those seen in individuals with rhabdoid tumors [<a class="bk_pop" href="#schwann.REF.smith.2014.373">Smith et al 2014</a>] (see <a class="figpopup" href="/books/NBK487394/table/schwann.T.allelic_disorders/?report=objectonly" target="object" rid-figpopup="figschwannTallelicdisorders" rid-ob="figobschwannTallelicdisorders">Table 2</a>). Schwannomatosis-associated <i>SMARCB1</i> variants are significantly more often located at the 5' or 3' end of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, including the 3'-untranslated region where the most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is located, i.e., <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003073.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003073.4</a>:c.*82C&#x0003e;T. Schwannomatosis-associated <i>SMARCB1</i> pathogenic variants are predominantly <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> nontruncating (i.e., <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>, or <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>) variants [<a class="bk_pop" href="#schwann.REF.swensen.2009.68">Swensen et al 2009</a>, <a class="bk_pop" href="#schwann.REF.eaton.2011.7">Eaton et al 2011</a>, <a class="bk_pop" href="#schwann.REF.carter.2012.154">Carter et al 2012</a>, <a class="bk_pop" href="#schwann.REF.smith.2012.141">Smith et al 2012</a>, <a class="bk_pop" href="#schwann.REF.smith.2015.141">Smith et al 2015</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> SMARCB1 has 394 amino acids and was originally called hSNF5/INI1. It was first identified as an interacting protein for HIV-1 integrase. Its role as a tumor suppressor has been established. It encodes for a subunit of the SWI/SNF chromatin remodeling complex. It is important for both the assembly and targeting of the SWI/SNF complex to gene promoters [<a class="bk_pop" href="#schwann.REF.kuwahara.2013.251">Kuwahara et al 2013</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Germline pathogenic variants are thought to be <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> in the context of schwannomatosis, and <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> in the context of <a href="/books/n/gene/rtps/">rhabdoid tumor predisposition syndrome</a>.</p></div><div id="schwann.Cancer_and_Benign_Tumors"><h4>Cancer and Benign Tumors</h4><p><b><i>LZTR1.</i></b> Sporadic glioblastomas occurring as single tumors in the absence of any other findings of schwannomatosis may harbor somatic variants in <i>LZTR1</i> that are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>. In these circumstances predisposition to these tumors is not heritable. Somatic <i>LZTR1</i> pathogenic variants are identified in about one fifth of glioblastomas [<a class="bk_pop" href="#schwann.REF.frattini.2013.1141">Frattini et al 2013</a>].</p><p><b><i>SMARCB1</i>.</b> Sporadic meningiomas occurring as single tumors in the absence of any other findings of schwannomatosis may harbor somatic variants in <i>SMARCB1</i> that are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> [<a class="bk_pop" href="#schwann.REF.schmitz.2001.199">Schmitz et al 2001</a>, <a class="bk_pop" href="#schwann.REF.rieske.2003.299">Rieske et al 2003</a>]. In these circumstances predisposition to these tumors is not heritable.</p></div></div></div><div id="schwann.References"><h2 id="_schwann_References_">References</h2><div id="schwann.Published_Guidelines__Consensus"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.evans.2017.e54">Evans DGR, Salvador H, Chang VY, Erez A, Voss SD, Druker H, Scott HS, Tabori U. Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 2 and related disorders. <span><span class="ref-journal">Clin Cancer Res. </span>2017;<span class="ref-vol">23</span>:e54–e61.</span> [<a href="/pubmed/28620005" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28620005</span></a>]</div></li></ul></div><div id="schwann.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.aavikko.2012.520">Aavikko M, Li SP, Saarinen S, Alhopuro P, Kaasinen E, Morgunova E, Li Y, Vesanen K, Smith MJ, Evans DG, P&#x000f6;yh&#x000f6;nen M, Kiuru A, Auvinen A, Aaltonen LA, Taipale J, Vahteristo P. Loss of SUFU function in familial multiple meningioma. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">91</span>:520–6.</span> [<a href="/pmc/articles/PMC3511996/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3511996</span></a>] [<a href="/pubmed/22958902" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22958902</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.antinheimo.2000.71">Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. <span><span class="ref-journal">Neurology. </span>2000;<span class="ref-vol">54</span>:71–6.</span> [<a href="/pubmed/10636128" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10636128</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.bacci.2010.73">Bacci C, Sestini R, Provenzano A, Paganini I, Mancini I, Porfirio B, Vivarelli R, Genuardi M, Papi L. Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. <span><span class="ref-journal">Neurogenetics. </span>2010;<span class="ref-vol">11</span>:73–80.</span> [<a href="/pubmed/19582488" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19582488</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.boyd.2008.358">Boyd C, Smith MJ, Kluwe L, Balogh A, MacCollin M, Plotkin SR. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. <span><span class="ref-journal">Clin Genet. </span>2008;<span class="ref-vol">74</span>:358–66.</span> [<a href="/pubmed/18647326" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18647326</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.bourdeaut.2011.31">Bourdeaut F, Lequin D, Brugi&#x000e8;res L, Reynaud S, Dufour C, Doz F, Andr&#x000e9; N, Stephan JL, P&#x000e9;rel Y, Oberlin O, Orbach D, Bergeron C, Rialland X, Fr&#x000e9;neaux P, Ranchere D, Figarella-Branger D, Audry G, Puget S, Evans DG, Pinas JC, Capra V, Mosseri V, Coupier I, Gauthier-Villars M, Pierron G, Delattre O. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. <span><span class="ref-journal">Clin Cancer Res. </span>2011;<span class="ref-vol">17</span>:31–8.</span> [<a href="/pubmed/21208904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21208904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.carter.2012.154">Carter JM, O'hara C, Dundas G, Gilchrist D, Collins MS, Eaton K, Judkins AR, Biegel JA, Folpe AL. Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with "neuroblastoma-like" schwannomatosis and a novel germline SMARCB1 mutation. <span><span class="ref-journal">Am J Surg Pathol. </span>2012;<span class="ref-vol">36</span>:154–60.</span> [<a href="/pmc/articles/PMC3241826/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3241826</span></a>] [<a href="/pubmed/22082606" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22082606</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.christiaans.2011.93">Christiaans I, Kenter SB, Brink HC, van Os TA, Baas F, van den Munckhof P, Kidd AM, Hulsebos TJ. Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:93–7.</span> [<a href="/pubmed/20930055" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20930055</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.eaton.2011.7">Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2011;<span class="ref-vol">56</span>:7–15.</span> [<a href="/pmc/articles/PMC3086793/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3086793</span></a>] [<a href="/pubmed/21108436" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21108436</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.evans.2006.289">Evans DG, Birch JM, Ramsden RT, Sharif S, Baser ME. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:289–94.</span> [<a href="/pmc/articles/PMC2563223/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2563223</span></a>] [<a href="/pubmed/16155191" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16155191</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.evans.2012.17">Evans DG, Huson SM, Birch JM. Malignant peripheral nerve sheath tumours in inherited disease. <span><span class="ref-journal">Clin Sarcoma Res. </span>2012;<span class="ref-vol">2</span>:17.</span> [<a href="/pmc/articles/PMC3499223/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3499223</span></a>] [<a href="/pubmed/23036231" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23036231</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.evans.2017.e54_1">Evans DGR, Salvador H, Chang VY, Erez A, Voss SD, Druker H, Scott HS, Tabori U. Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 2 and related disorders. <span><span class="ref-journal">Clin Cancer Res. </span>2017;<span class="ref-vol">23</span>:e54–e61.</span> [<a href="/pubmed/28620005" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28620005</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.farschtschi.2016.625">Farschtschi S, Mautner VF, Pham M, Nguyen R, Kehrer-Sawatzki H, Hutter S, Friedrich RE, Schulz A, Morrison H, Jones DT, Bendszus M, Baumer P. Multifocal nerve lesions and LZTR1 germline mutations in segmental schwannomatosis. <span><span class="ref-journal">Ann Neurol. </span>2016;<span class="ref-vol">80</span>:625–8.</span> [<a href="/pubmed/27472264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27472264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.frattini.2013.1141">Frattini V, Trifonov V, Chan JM, Castano A, Lia M, Abate F, Keir ST, Ji AX, Zoppoli P, Niola F, Danussi C, Dolgalev I, Porrati P, Pellegatta S, Heguy A, Gupta G, Pisapia DJ, Canoll P, Bruce JN, Mclendon RE, Yan H, Aldape K, Finocchiaro G, Mikkelsen T, Prive GG, Bigner DD, Lasorella A, Rabadan R, Iavarone A. The integrated landscape of driver genomic alterations in glioblastoma. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:1141–9.</span> [<a href="/pmc/articles/PMC3799953/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3799953</span></a>] [<a href="/pubmed/23917401" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23917401</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.gonzalvo.2011.756">Gonzalvo A, Fowler A, Cook RJ, Little NS, Wheeler H, Mcdonald KL, Biggs MT. Schwannomatosis, sporadic schwannomatosis, and familial schwannomatosis: a surgical series with long-term follow-up. Clinical article. <span><span class="ref-journal">J Neurosurg. </span>2011;<span class="ref-vol">114</span>:756–62.</span> [<a href="/pubmed/20932094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20932094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.gossai.2015.3186">Gossai N, Biegel JA, Messiaen L, Berry SA, Moertel CL. Report of a patient with a constitutional missense mutation in SMARCB1, Coffin-Siris phenotype, and schwannomatosis. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:3186–91.</span> [<a href="/pubmed/26364901" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26364901</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.gripp.2017.540">Gripp KW, Baker L, Kandula V, Piatt J, Walter A, Chen Z, Messiaen L. Constitutional LZTR1 mutation presenting with a unilateral vestibular schwannoma in a teenager. <span><span class="ref-journal">Clin Genet. </span>2017;<span class="ref-vol">92</span>:540–3.</span> [<a href="/pubmed/28295212" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28295212</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.hadfield.2008.332">Hadfield KD, Newman WG, Bowers NL, Wallace A, Bolger C, Colley A, Mccann E, Trump D, Prescott T, Evans DG. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. <span><span class="ref-journal">J Med Genet. </span>2008;<span class="ref-vol">45</span>:332–9.</span> [<a href="/pubmed/18285426" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18285426</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.hadfield.2010.6216">Hadfield KD, Smith MJ, Urquhart JE, Wallace AJ, Bowers NL, King AT, Rutherford SA, Trump D, Newman WG, Evans DG. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. <span><span class="ref-journal">Oncogene. </span>2010;<span class="ref-vol">29</span>:6216–21.</span> [<a href="/pubmed/20729918" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20729918</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.hulsebos.2016.350">Hulsebos TJ, Kenter S, Baas F, Nannenberg EA, Bleeker FE, van Minkelen R, van den Ouweland AM, Wesseling P, Flucke U. Type 1 papillary renal cell carcinoma in a patient with schwannomatosis: Mosaic versus loss of SMARCB1 expression in respectively schwannoma and renal tumor cells. <span><span class="ref-journal">Genes Chromosomes Cancer. </span>2016;<span class="ref-vol">55</span>:350–4.</span> [<a href="/pubmed/26799435" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26799435</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.hulsebos.2010.86">Hulsebos TJ, Kenter SB, Jakobs ME, Baas F, Chong B, Delatycki MB. SMARCB1/INI1 maternal germ line mosaicism in schwannomatosis. <span><span class="ref-journal">Clin Genet. </span>2010;<span class="ref-vol">77</span>:86–91.</span> [<a href="/pubmed/19912265" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19912265</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.hutter.2014.449">Hutter S, Piro RM, Reuss DE, Hovestadt V, Sahm F, Farschtschi S, Kehrer-Sawatzki H, Wolf S, Lichter P, von Deimling A, Schuhmann MU, Pfister SM, Jones DT, Mautner VF. Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants. <span><span class="ref-journal">Acta Neuropathol. </span>2014;<span class="ref-vol">128</span>:449–52.</span> [<a href="/pubmed/25008767" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25008767</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.kehrersawatzki.2017.129">Kehrer-Sawatzki H, Farschtschi S, Mautner VF, Cooper DN. The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple Tumour Suppressor Genes In Tumorigenesis. <span><span class="ref-journal">Hum Genet. </span>2017;<span class="ref-vol">136</span>:129–148.</span> [<a href="/pmc/articles/PMC5258795/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5258795</span></a>] [<a href="/pubmed/27921248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27921248</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.kondziolka.1998.1426">Kondziolka D, Lunsford LD, Mclaughlin MR, Flickinger JC. Long-term outcomes after radiosurgery for acoustic neuromas. <span><span class="ref-journal">N Engl J Med. </span>1998;<span class="ref-vol">339</span>:1426–33.</span> [<a href="/pubmed/9811917" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9811917</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.koontz.2013.w64653">Koontz NA, Wiens AL, Agarwal A, Hingtgen CM, Emerson RE, Mosier KM. Schwannomatosis: the overlooked neurofibromatosis? <span><span class="ref-journal">AJR Am J Roentgenol. </span>2013;<span class="ref-vol">200</span>:W646-53.</span> [<a href="/pubmed/23701098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23701098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.kuwahara.2013.251">Kuwahara Y, Wei D, Durand J, Weissman BE. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters. <span><span class="ref-journal">Mol Cancer Res. </span>2013;<span class="ref-vol">11</span>:251–60.</span> [<a href="/pmc/articles/PMC4342046/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4342046</span></a>] [<a href="/pubmed/23364536" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23364536</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.li.2016.145">Li P, Zhao F, Zhang J, Wang Z, Wang X, Wang B, Yang Z, Yang J, Gao Z, Liu P. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution. <span><span class="ref-journal">J Neurosurg Spine. </span>2016;<span class="ref-vol">24</span>:145–54.</span> [<a href="/pubmed/26407091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26407091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.maccollin.2005.1838">MacCollin M, Chiocca EA, Evans DG, Friedman JM, Horvitz R, Jaramillo D, Lev M, Mautner VF, Niimura M, Plotkin SR, Sang CN, Stemmer-Rachamimov A, Roach ES. Diagnostic criteria for schwannomatosis. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:1838–45.</span> [<a href="/pubmed/15955931" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15955931</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.melean.2012.267">Melean G, Velasco A, Hernandez-Imaz E, Rodriguez-Alvarez FJ, Martin Y, Valero A, Hernandez-Chico C. RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas. <span><span class="ref-journal">Neurogenetics. </span>2012;<span class="ref-vol">13</span>:267–74.</span> [<a href="/pubmed/22752724" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22752724</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.merker.2014.1431">Merker VL, Bredella MA, Cai W, Kassarjian A, Harris GJ, Muzikansky A, Nguyen R, Mautner VF, Plotkin SR. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis. <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:1431–7.</span> [<a href="/pubmed/24664633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24664633</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.merker.2012.1317">Merker VL, Esparza S, Smith MJ, Stemmer-Rachamimov A, Plotkin SR. Clinical features of schwannomatosis: a retrospective analysis of 87 patients. <span><span class="ref-journal">Oncologist. </span>2012;<span class="ref-vol">17</span>:1317–22.</span> [<a href="/pmc/articles/PMC3481897/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3481897</span></a>] [<a href="/pubmed/22927469" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22927469</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.ostrow.2017.407">Ostrow KL, Bergner AL, Blakeley J, Evans DG, Ferner R, Friedman JM, Harris GJ, Jordan JT, Korf B, Langmead S, Leschziner G, Mautner V, Merker VL, Papi L, Plotkin SR, Slopis JM, Smith MJ, Stemmer-Rachamimov A, Yohay K, Belzberg AJ. Creation of an international registry to support discovery in schwannomatosis. <span><span class="ref-journal">Am J Med Genet A. </span>2017;<span class="ref-vol">173</span>:407–413.</span> [<a href="/pubmed/27759912" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27759912</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.paganini.2015.963">Paganini I, Chang VY, Capone GL, Vitte J, Benelli M, Barbetti L, Sestini R, Trevisson E, Hulsebos TJ, Giovannini M, Nelson SF, Papi L. Expanding the mutational spectrum of LZTR1 in schwannomatosis. <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>:963–8.</span> [<a href="/pmc/articles/PMC4463507/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4463507</span></a>] [<a href="/pubmed/25335493" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25335493</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.piotrowski.2014.182">Piotrowski A, Xie J, Liu YF, Poplawski AB, Gomes AR, Madanecki P, Fu C, Crowley MR, Crossman DK, Armstrong L, Babovic-Vuksanovic D, Bergner A, Blakeley JO, Blumenthal AL, Daniels MS, Feit H, Gardner K, Hurst S, Kobelka C, Lee C, Nagy R, Rauen KA, Slopis JM, Suwannarat P, Westman JA, Zanko A, Korf BR, Messiaen LM. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. <span><span class="ref-journal">Nat Genet. </span>2014;<span class="ref-vol">46</span>:182–7.</span> [<a href="/pmc/articles/PMC4352302/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4352302</span></a>] [<a href="/pubmed/24362817" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24362817</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.plotkin.2013.405">Plotkin SR, Blakeley JO, Evans DG, Hanemann CO, Hulsebos TJ, Hunter-Schaedle K, Kalpana GV, Korf B, Messiaen L, Papi L, Ratner N, Sherman LS, Smith MJ, Stemmer-Rachamimov AO, Vitte J, Giovannini M. Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:405–16.</span> [<a href="/pmc/articles/PMC4020435/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4020435</span></a>] [<a href="/pubmed/23401320" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23401320</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.plotkin.2012.e35711">Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S, Merker VL, Munn LL, Muzikansky A, Askenazi M, Nguyen R, Wenzel R, Mautner VF. Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. <span><span class="ref-journal">PLoS One. </span>2012;<span class="ref-vol">7</span>:e35711.</span> [<a href="/pmc/articles/PMC3338705/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3338705</span></a>] [<a href="/pubmed/22558206" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22558206</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.rieske.2003.299">Rieske P, Zakrzewska M, Piaskowski S, Jaskolski D, Sikorska B, Papierz W, Zakrzewski K, Liberski PP. Molecular heterogeneity of meningioma with INI1 mutation. <span><span class="ref-journal">Mol Pathol. </span>2003;<span class="ref-vol">56</span>:299–301.</span> [<a href="/pmc/articles/PMC1187342/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1187342</span></a>] [<a href="/pubmed/14514925" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14514925</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.rousseau.2011.9">Rousseau G, Noguchi T, Bourdon V, Sobol H, Olschwang S. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis. <span><span class="ref-journal">BMC Neurol. </span>2011;<span class="ref-vol">11</span>:9.</span> [<a href="/pmc/articles/PMC3037869/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3037869</span></a>] [<a href="/pubmed/21255467" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21255467</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.schmitz.2001.199">Schmitz U, Mueller W, Weber M, Sevenet N, Delattre O, Von Deimling A. INI1 mutations in meningiomas at a potential hotspot in exon 9. <span><span class="ref-journal">Br J Cancer. </span>2001;<span class="ref-vol">84</span>:199–201.</span> [<a href="/pmc/articles/PMC2363707/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2363707</span></a>] [<a href="/pubmed/11161377" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11161377</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.sestini.2008.227">Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. <span><span class="ref-journal">Hum Mutat. </span>2008;<span class="ref-vol">29</span>:227–31.</span> [<a href="/pubmed/18072270" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18072270</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.smith.2017.87">Smith MJ, Bowers NL, Bulman M, Gokhale C, Wallace AJ, King AT, Lloyd SK, Rutherford SA, Hammerbeck-Ward CL, Freeman SR, Evans DG. Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis. <span><span class="ref-journal">Neurology. </span>2017;<span class="ref-vol">88</span>:87–92.</span> [<a href="/pmc/articles/PMC5200853/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5200853</span></a>] [<a href="/pubmed/27856782" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27856782</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.smith.2015.141">Smith MJ, Isidor B, Beetz C, Williams SG, Bhaskar SS, Richer W, O'Sullivan J, Anderson B, Daly SB, Urquhart JE, Fryer A, Rustad CF, Mills SJ, Samii A, Du Plessis D, Halliday D, Barbarot S, Bourdeaut F, Newman WG, Evans DG. Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">84</span>:141–7.</span> [<a href="/pmc/articles/PMC4336087/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4336087</span></a>] [<a href="/pubmed/25480913" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25480913</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.smith.2014.373">Smith MJ, Wallace AJ, Bowers NL, Eaton H, Evans DG. SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors. <span><span class="ref-journal">Cancer Genet. </span>2014;<span class="ref-vol">207</span>:373–8.</span> [<a href="/pubmed/24933152" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24933152</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.smith.2012.141">Smith MJ, Wallace AJ, Bowers NL, Rustad CF, Woods CG, Leschziner GD, Ferner RE, Evans DG. Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis. <span><span class="ref-journal">Neurogenetics. </span>2012;<span class="ref-vol">13</span>:141–5.</span> [<a href="/pubmed/22434358" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22434358</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.swensen.2009.68">Swensen JJ, Keyser J, Coffin CM, Biegel JA, Viskochil DH, Williams MS. Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:68–72.</span> [<a href="/pmc/articles/PMC2843150/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2843150</span></a>] [<a href="/pubmed/19124645" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19124645</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="schwann.REF.van_den_munckhof.2012.1">van den Munckhof P, Christiaans I, Kenter SB, Baas F, Hulsebos TJ. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri. <span><span class="ref-journal">Neurogenetics. </span>2012;<span class="ref-vol">13</span>:1–7.</span> [<a href="/pubmed/22038540" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22038540</span></a>]</div></li></ul></div></div><div id="schwann.Chapter_Notes"><h2 id="_schwann_Chapter_Notes_">Chapter Notes</h2><div id="schwann.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>8 March 2018 (sw) Review posted live</div></li><li class="half_rhythm"><div>14 July 2017 (rd) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK487394</span><span class="label">PMID: <a href="/pubmed/29517885" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">29517885</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/schmid-mcd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/spr-def/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK487394&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK487394/?report=reader">PubReader</a></li><li><a href="/books/NBK487394/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK487394" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK487394" style="display:none" title="Cite this Page"><div class="bk_tt">Dhamija R, Plotkin S, Asthagiri A, et al. Schwannomatosis. 2018 Mar 8. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK487394/pdf/Bookshelf_NBK487394.pdf">PDF version of this page</a> (226K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#schwann.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#schwann.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#schwann.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#schwann.Genetically_Related_Allelic_Diso" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#schwann.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#schwann.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#schwann.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#schwann.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#schwann.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#schwann.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#schwann.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8216[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LZTR1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4771[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NF2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6598[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SMARCB1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4512564" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4512564" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4512564" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4512564" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29215836" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Rhabdoid Tumor Predisposition Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Rhabdoid Tumor Predisposition Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nemes K, Bens S, Bourdeaut F, Hasselblatt M, Kool M, Johann P, Kordes U, Schneppenheim R, Siebert R, Frühwald MC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28365909" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.</a><span class="source">[Childs Nerv Syst. 2017]</span><div class="brieflinkpop offscreen_noflow">A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Caltabiano R, Magro G, Polizzi A, Praticò AD, Ortensi A, D'Orazi V, Panunzi A, Milone P, Maiolino L, Nicita F, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Childs Nerv Syst. 2017 Jun; 33(6):933-940. Epub 2017 Apr 1.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301303" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Noonan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Noonan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Allanson JE, Roberts AE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30006736" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.</a><span class="source">[Hum Genet. 2018]</span><div class="brieflinkpop offscreen_noflow">Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kehrer-Sawatzki H, Kluwe L, Friedrich RE, Summerer A, Schäfer E, Wahlländer U, Matthies C, Gugel I, Farschtschi S, Hagel C, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Genet. 2018 Jul; 137(6-7):543-552. Epub 2018 Jul 13.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31128261" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Coexistence of schwannomatosis and glioblastoma in two families.</a><span class="source">[Eur J Med Genet. 2019]</span><div class="brieflinkpop offscreen_noflow">Coexistence of schwannomatosis and glioblastoma in two families.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Deiller C, Van-Gils J, Zordan C, Tinat J, Loiseau H, Fabre T, Delleci C, Cohen J, Vidaud M, Parfait B, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Med Genet. 2019 Aug; 62(8):103680. Epub 2019 May 22.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=29517885" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=29517885" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04187c39a66ee2ba40f0ac">Schwannomatosis - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Schwannomatosis - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:18:36-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D90B1E04184A1000000000015000C&amp;ncbi_session=CE8D90B1E04187B1_0021SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK487394%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK487394&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK487394/&amp;ncbi_pagename=Schwannomatosis - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D90B1E04187B1_0021SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>